Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

[Rhabdomyolysis after isotretinoin treatment in a 17-year-old male].

Paulsrud C, Stender IM, Schmidt LS.

Ugeskr Laeger. 2017 Oct 2;179(40). pii: V06170462. Danish.

PMID:
28992847
2.

FLCN: The causative gene for Birt-Hogg-Dubé syndrome.

Schmidt LS, Linehan WM.

Gene. 2018 Jan 15;640:28-42. doi: 10.1016/j.gene.2017.09.044. Epub 2017 Sep 29. Review.

PMID:
28970150
3.

A mouse model of renal cell carcinoma.

Schmidt LS, Linehan WM.

Nat Med. 2017 Jul 11;23(7):802-803. doi: 10.1038/nm.4366. No abstract available.

PMID:
28697179
4.

EEG with extreme delta brush in young female with methotrexate neurotoxicity supports NMDA receptor involvement.

Schmidt LS, Kjær TW, Schmiegelow K, Born AP.

Eur J Paediatr Neurol. 2017 Sep;21(5):795-797. doi: 10.1016/j.ejpn.2017.05.008. Epub 2017 Jun 15.

PMID:
28655493
5.

[Epidural abscess secondary to sinusitis].

Henriksen P, Yazdanyar N, Schmidt LS, Frederiksen MS.

Ugeskr Laeger. 2016 Dec 26;178(52). pii: V10160754. Danish.

PMID:
28041546
6.

H255Y and K508R missense mutations in tumour suppressor folliculin (FLCN) promote kidney cell proliferation.

Hasumi H, Hasumi Y, Baba M, Nishi H, Furuya M, Vocke CD, Lang M, Irie N, Esumi C, Merino MJ, Kawahara T, Isono Y, Makiyama K, Warner AC, Haines DC, Wei MH, Zbar B, Hagenau H, Feigenbaum L, Kondo K, Nakaigawa N, Yao M, Metwalli AR, Marston Linehan W, Schmidt LS.

Hum Mol Genet. 2017 Jan 15;26(2):354-366. doi: 10.1093/hmg/ddw392.

PMID:
28007907
7.

Genetic predisposition to kidney cancer.

Schmidt LS, Linehan WM.

Semin Oncol. 2016 Oct;43(5):566-574. doi: 10.1053/j.seminoncol.2016.09.001. Epub 2016 Sep 22. Review.

8.

Prenatal and Postnatal Medical Conditions and the Risk of Brain Tumors in Children and Adolescents: An International Multicenter Case-Control Study.

Tettamanti G, Shu X, Adel Fahmideh M, Schüz J, Röösli M, Tynes T, Grotzer M, Johansen C, Klaeboe L, Kuehni CE, Lannering B, Schmidt LS, Vienneau D, Feychting M.

Cancer Epidemiol Biomarkers Prev. 2017 Jan;26(1):110-115. doi: 10.1158/1055-9965.EPI-16-0451. Epub 2016 Sep 13.

9.

Common genetic variations in cell cycle and DNA repair pathways associated with pediatric brain tumor susceptibility.

Adel Fahmideh M, Lavebratt C, Schüz J, Röösli M, Tynes T, Grotzer MA, Johansen C, Kuehni CE, Lannering B, Prochazka M, Schmidt LS, Feychting M.

Oncotarget. 2016 Sep 27;7(39):63640-63650. doi: 10.18632/oncotarget.11575.

10.

The FNIP co-chaperones decelerate the Hsp90 chaperone cycle and enhance drug binding.

Woodford MR, Dunn DM, Blanden AR, Capriotti D, Loiselle D, Prodromou C, Panaretou B, Hughes PF, Smith A, Ackerman W, Haystead TA, Loh SN, Bourboulia D, Schmidt LS, Marston Linehan W, Bratslavsky G, Mollapour M.

Nat Commun. 2016 Jun 29;7:12037. doi: 10.1038/ncomms12037.

11.

Loss of Folliculin Disrupts Hematopoietic Stem Cell Quiescence and Homeostasis Resulting in Bone Marrow Failure.

Baba M, Toyama H, Sun L, Takubo K, Suh HC, Hasumi H, Nakamura-Ishizu A, Hasumi Y, Klarmann KD, Nakagata N, Schmidt LS, Linehan WM, Suda T, Keller JR.

Stem Cells. 2016 Apr;34(4):1068-82. doi: 10.1002/stem.2293. Epub 2016 Feb 2.

12.

SnapShot: Renal Cell Carcinoma.

Ricketts CJ, Crooks DR, Sourbier C, Schmidt LS, Srinivasan R, Linehan WM.

Cancer Cell. 2016 Apr 11;29(4):610-610.e1. doi: 10.1016/j.ccell.2016.03.021.

13.

A multinational case-control study on childhood brain tumours, anthropogenic factors, birth characteristics and prenatal exposures: A validation of interview data.

Vienneau D, Infanger D, Feychting M, Schüz J, Schmidt LS, Poulsen AH, Tettamanti G, Klæboe L, Kuehni CE, Tynes T, Von der Weid N, Lannering B, Röösli M.

Cancer Epidemiol. 2016 Feb;40:52-9. doi: 10.1016/j.canep.2015.11.006. Epub 2015 Nov 25.

PMID:
26625087
14.

Clinical Features, Genetics and Potential Therapeutic Approaches for Birt-Hogg-Dubé Syndrome.

Schmidt LS, Linehan WM.

Expert Opin Orphan Drugs. 2015;3(1):15-29. Epub 2014 Nov 29.

15.

Mitochondrial DNA mutations distinguish bilateral multifocal renal oncocytomas from familial Birt-Hogg-Dubé tumors.

Lang M, Vocke CD, Merino MJ, Schmidt LS, Linehan WM.

Mod Pathol. 2015 Nov;28(11):1458-69. doi: 10.1038/modpathol.2015.101. Epub 2015 Oct 2.

16.

Molecular genetics and clinical features of Birt-Hogg-Dubé syndrome.

Schmidt LS, Linehan WM.

Nat Rev Urol. 2015 Oct;12(10):558-69. doi: 10.1038/nrurol.2015.206. Epub 2015 Sep 1. Review.

17.

CCDC26, CDKN2BAS, RTEL1 and TERT Polymorphisms in pediatric brain tumor susceptibility.

Adel Fahmideh M, Lavebratt C, Schüz J, Röösli M, Tynes T, Grotzer MA, Johansen C, Kuehni CE, Lannering B, Prochazka M, Schmidt LS, Feychting M.

Carcinogenesis. 2015 Aug;36(8):876-82. doi: 10.1093/carcin/bgv074. Epub 2015 May 25.

18.

Suicide and Self-Determination.

Baumrucker SJ, Carter GT, McCall-Burton M, Stolick M, Oertli KA, Schmidt LS, Adkins RW.

Am J Hosp Palliat Care. 2016 Sep;33(8):807-12. doi: 10.1177/1049909115577933. Epub 2015 Mar 23. No abstract available.

PMID:
25804216
19.

Folliculin-interacting proteins Fnip1 and Fnip2 play critical roles in kidney tumor suppression in cooperation with Flcn.

Hasumi H, Baba M, Hasumi Y, Lang M, Huang Y, Oh HF, Matsuo M, Merino MJ, Yao M, Ito Y, Furuya M, Iribe Y, Kodama T, Southon E, Tessarollo L, Nagashima K, Haines DC, Linehan WM, Schmidt LS.

Proc Natl Acad Sci U S A. 2015 Mar 31;112(13):E1624-31. doi: 10.1073/pnas.1419502112. Epub 2015 Mar 16.

20.

The somatic genomic landscape of chromophobe renal cell carcinoma.

Davis CF, Ricketts CJ, Wang M, Yang L, Cherniack AD, Shen H, Buhay C, Kang H, Kim SC, Fahey CC, Hacker KE, Bhanot G, Gordenin DA, Chu A, Gunaratne PH, Biehl M, Seth S, Kaipparettu BA, Bristow CA, Donehower LA, Wallen EM, Smith AB, Tickoo SK, Tamboli P, Reuter V, Schmidt LS, Hsieh JJ, Choueiri TK, Hakimi AA; The Cancer Genome Atlas Research Network, Chin L, Meyerson M, Kucherlapati R, Park WY, Robertson AG, Laird PW, Henske EP, Kwiatkowski DJ, Park PJ, Morgan M, Shuch B, Muzny D, Wheeler DA, Linehan WM, Gibbs RA, Rathmell WK, Creighton CJ.

Cancer Cell. 2014 Sep 8;26(3):319-330. doi: 10.1016/j.ccr.2014.07.014. Epub 2014 Aug 21.

21.

Hereditary leiomyomatosis and renal cell carcinoma.

Schmidt LS, Linehan WM.

Int J Nephrol Renovasc Dis. 2014 Jun 20;7:253-60. doi: 10.2147/IJNRD.S42097. eCollection 2014. Review.

22.

Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment.

Menko FH, Maher ER, Schmidt LS, Middelton LA, Aittomäki K, Tomlinson I, Richard S, Linehan WM.

Fam Cancer. 2014 Dec;13(4):637-44. doi: 10.1007/s10689-014-9735-2. Review.

23.

Folliculin (Flcn) inactivation leads to murine cardiac hypertrophy through mTORC1 deregulation.

Hasumi Y, Baba M, Hasumi H, Huang Y, Lang M, Reindorf R, Oh HB, Sciarretta S, Nagashima K, Haines DC, Schneider MD, Adelstein RS, Schmidt LS, Sadoshima J, Marston Linehan W.

Hum Mol Genet. 2014 Nov 1;23(21):5706-19. doi: 10.1093/hmg/ddu286. Epub 2014 Jun 6.

24.

Life Support After Brain Death.

Baumrucker SJ, Hutchinson L, Stolick M, Carter GT, Oertli K, Schmidt LS, Adkins RW.

Am J Hosp Palliat Care. 2015 Sep;32(6):672-8. doi: 10.1177/1049909114528065. Epub 2014 Apr 11. No abstract available.

PMID:
24728203
25.

Folliculin controls lung alveolar enlargement and epithelial cell survival through E-cadherin, LKB1, and AMPK.

Goncharova EA, Goncharov DA, James ML, Atochina-Vasserman EN, Stepanova V, Hong SB, Li H, Gonzales L, Baba M, Linehan WM, Gow AJ, Margulies S, Guttentag S, Schmidt LS, Krymskaya VP.

Cell Rep. 2014 Apr 24;7(2):412-23. doi: 10.1016/j.celrep.2014.03.025. Epub 2014 Apr 13.

26.

Atopic conditions and brain tumor risk in children and adolescents--an international case-control study (CEFALO).

Shu X, Prochazka M, Lannering B, Schüz J, Röösli M, Tynes T, Kuehni CE, Andersen TV, Infanger D, Schmidt LS, Poulsen AH, Klaeboe L, Eggen T, Feychting M.

Ann Oncol. 2014 Apr;25(4):902-8. doi: 10.1093/annonc/mdu048. Epub 2014 Mar 7.

PMID:
24608192
27.

Editorial comment.

Schmidt LS, Linehan WM.

Urology. 2014 Mar;83(3):675.e5; discussion 675.e5-6. doi: 10.1016/j.urology.2013.09.070. No abstract available.

28.

The allegedly abusive surrogate.

Baumrucker SJ, Schmidt LS, Stolick M, Adkins RW, Oertli RK, McCall-Burton M, VandeKieft G.

Am J Hosp Palliat Care. 2015 Feb;32(1):112-6. doi: 10.1177/1049909113507125. Epub 2013 Oct 4. Review. No abstract available.

PMID:
24097837
29.

The deathbed confession.

Baumrucker SJ, Carter GT, Adkins RW, Stolick M, McCall-Burton M, Schmidt LS, Oertli RK.

Am J Hosp Palliat Care. 2014 Aug;31(5):576-80. doi: 10.1177/1049909113495708. Epub 2013 Aug 8. Review. No abstract available.

PMID:
23928075
30.

Whose "best interests" are at stake?

Baumrucker SJ, Oertli RK, Stolick M, McCall-Burton M, Schmidt LS, Adkins RW, VandeKieft G.

Am J Hosp Palliat Care. 2014 Sep;31(6):685-91. doi: 10.1177/1049909113495709. Epub 2013 Jul 17. Review. No abstract available.

PMID:
23869028
31.

A novel germline mutation in BAP1 predisposes to familial clear-cell renal cell carcinoma.

Farley MN, Schmidt LS, Mester JL, Pena-Llopis S, Pavia-Jimenez A, Christie A, Vocke CD, Ricketts CJ, Peterson J, Middelton L, Kinch L, Grishin N, Merino MJ, Metwalli AR, Xing C, Xie XJ, Dahia PLM, Eng C, Linehan WM, Brugarolas J.

Mol Cancer Res. 2013 Sep;11(9):1061-1071. doi: 10.1158/1541-7786.MCR-13-0111. Epub 2013 May 24.

32.

Patterns of exposure to infectious diseases and social contacts in early life and risk of brain tumours in children and adolescents: an International Case-Control Study (CEFALO).

Andersen TV, Schmidt LS, Poulsen AH, Feychting M, Röösli M, Tynes T, Aydin D, Prochazka M, Lannering B, Klæboe L, Eggen T, Kuehni CE, Schmiegelow K, Schüz J.

Br J Cancer. 2013 Jun 11;108(11):2346-53. doi: 10.1038/bjc.2013.201. Epub 2013 May 7.

33.

Regulation of mitochondrial oxidative metabolism by tumor suppressor FLCN.

Hasumi H, Baba M, Hasumi Y, Huang Y, Oh H, Hughes RM, Klein ME, Takikita S, Nagashima K, Schmidt LS, Linehan WM.

J Natl Cancer Inst. 2012 Nov 21;104(22):1750-64. doi: 10.1093/jnci/djs418. Epub 2012 Nov 12.

34.

Birt-Hogg-Dubé syndrome: from gene discovery to molecularly targeted therapies.

Schmidt LS.

Fam Cancer. 2013 Sep;12(3):357-64. doi: 10.1007/s10689-012-9574-y. Erratum in: Fam Cancer. 2013 Sep;12(3):365.

35.

Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer.

Ricketts CJ, Shuch B, Vocke CD, Metwalli AR, Bratslavsky G, Middelton L, Yang Y, Wei MH, Pautler SE, Peterson J, Stolle CA, Zbar B, Merino MJ, Schmidt LS, Pinto PA, Srinivasan R, Pacak K, Linehan WM.

J Urol. 2012 Dec;188(6):2063-71. doi: 10.1016/j.juro.2012.08.030. Epub 2012 Oct 18.

36.

Brain tumors in children and adolescents and exposure to animals and farm life: a multicenter case-control study (CEFALO).

Christensen JS, Mortensen LH, Röösli M, Feychting M, Tynes T, Andersen TV, Schmidt LS, Poulsen AH, Aydin D, Kuehni CE, Prochazka M, Lannering B, Klaeboe L, Eggen T, Schüz J.

Cancer Causes Control. 2012 Sep;23(9):1463-73. doi: 10.1007/s10552-012-0020-0. Epub 2012 Jul 12.

PMID:
22790303
37.

Surrogates with conflicting interests: who makes the decision?

Baumrucker SJ, Adkins RW, Stolick M, VandeKieft G, Schmidt LS, Mingle P.

Am J Hosp Palliat Care. 2012 Sep;29(6):497-500. doi: 10.1177/1049909112451104. Epub 2012 Jul 9. No abstract available.

PMID:
22777406
38.

The folliculin-FNIP1 pathway deleted in human Birt-Hogg-Dubé syndrome is required for murine B-cell development.

Baba M, Keller JR, Sun HW, Resch W, Kuchen S, Suh HC, Hasumi H, Hasumi Y, Kieffer-Kwon KR, Gonzalez CG, Hughes RM, Klein ME, Oh HF, Bible P, Southon E, Tessarollo L, Schmidt LS, Linehan WM, Casellas R.

Blood. 2012 Aug 9;120(6):1254-61. doi: 10.1182/blood-2012-02-410407. Epub 2012 Jun 18.

39.

When surrogates collide.

Baumrucker SJ, Carter GT, Mingle P, Stolick M, Oertli KA, Schmidt LS, Morris GM.

Am J Hosp Palliat Care. 2012 Jun;29(4):321-4. doi: 10.1177/1049909112440565. Epub 2012 Apr 10. No abstract available.

PMID:
22495796
40.

Hepatoblastoma in the Nordic countries.

de Fine Licht S, Schmidt LS, Rod NH, Schmiegelow K, Lähteenmäki PM, Kogner P, Träger C, Stokland T, Schüz J.

Int J Cancer. 2012 Aug 15;131(4):E555-61. doi: 10.1002/ijc.27351. Epub 2012 Jan 3.

41.

Von Hippel-Lindau (VHL) inactivation in sporadic clear cell renal cancer: associations with germline VHL polymorphisms and etiologic risk factors.

Moore LE, Nickerson ML, Brennan P, Toro JR, Jaeger E, Rinsky J, Han SS, Zaridze D, Matveev V, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Schmidt LS, Lenz P, Karami S, Linehan WM, Merino M, Chanock S, Boffetta P, Chow WH, Waldman FM, Rothman N.

PLoS Genet. 2011 Oct;7(10):e1002312. doi: 10.1371/journal.pgen.1002312. Epub 2011 Oct 13.

42.

Mobile phone use and brain tumors in children and adolescents: a multicenter case-control study.

Aydin D, Feychting M, Schüz J, Tynes T, Andersen TV, Schmidt LS, Poulsen AH, Johansen C, Prochazka M, Lannering B, Klæboe L, Eggen T, Jenni D, Grotzer M, Von der Weid N, Kuehni CE, Röösli M.

J Natl Cancer Inst. 2011 Aug 17;103(16):1264-76. doi: 10.1093/jnci/djr244. Epub 2011 Jul 27.

PMID:
21795665
43.

Identification of intragenic deletions and duplication in the FLCN gene in Birt-Hogg-Dubé syndrome.

Benhammou JN, Vocke CD, Santani A, Schmidt LS, Baba M, Seyama K, Wu X, Korolevich S, Nathanson KL, Stolle CA, Linehan WM.

Genes Chromosomes Cancer. 2011 Jun;50(6):466-77. doi: 10.1002/gcc.20872. Epub 2011 Mar 15.

44.

Increased cocaine self-administration in M4 muscarinic acetylcholine receptor knockout mice.

Schmidt LS, Thomsen M, Weikop P, Dencker D, Wess J, Woldbye DP, Wortwein G, Fink-Jensen A.

Psychopharmacology (Berl). 2011 Aug;216(3):367-78. doi: 10.1007/s00213-011-2225-4. Epub 2011 Mar 5.

45.

Antipsychotic-induced catalepsy is attenuated in mice lacking the M4 muscarinic acetylcholine receptor.

Fink-Jensen A, Schmidt LS, Dencker D, Schülein C, Wess J, Wörtwein G, Woldbye DP.

Eur J Pharmacol. 2011 Apr 10;656(1-3):39-44. doi: 10.1016/j.ejphar.2011.01.018. Epub 2011 Jan 24.

46.

Inactivation of the FLCN tumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localization.

Hong SB, Oh H, Valera VA, Baba M, Schmidt LS, Linehan WM.

PLoS One. 2010 Dec 29;5(12):e15793. doi: 10.1371/journal.pone.0015793.

47.

Incidence of childhood central nervous system tumors in the Nordic countries.

Schmidt LS, Schmiegelow K, Lahteenmaki P, Träger C, Stokland T, Grell K, Gustafson G, Sehested A, Raashou-Nielsen O, Johansen C, Schüz J.

Pediatr Blood Cancer. 2011 Jan;56(1):65-9. doi: 10.1002/pbc.22585.

PMID:
21108441
48.

Birth characteristics and Wilms tumors in children in the Nordic countries: a register-based case-control study.

Schüz J, Schmidt LS, Kogner P, Lähteenmäki PM, Pal N, Stokland T, Schmiegelow K.

Int J Cancer. 2011 May 1;128(9):2166-73. doi: 10.1002/ijc.25541.

49.

Tumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-beta signaling.

Hong SB, Oh H, Valera VA, Stull J, Ngo DT, Baba M, Merino MJ, Linehan WM, Schmidt LS.

Mol Cancer. 2010 Jun 23;9:160. doi: 10.1186/1476-4598-9-160.

50.

Infectious exposure in the first years of life and risk of central nervous system tumours in children: analysis of birth order, childcare attendance and seasonality of birth.

Schmidt LS, Kamper-Jørgensen M, Schmiegelow K, Johansen C, Lähteenmäki P, Träger C, Stokland T, Grell K, Gustafson G, Kogner P, Sehested A, Schüz J.

Br J Cancer. 2010 May 25;102(11):1670-5. doi: 10.1038/sj.bjc.6605679. Epub 2010 May 11.

Supplemental Content

Loading ...
Support Center